Author: Garner, Justin L.; Shah, Pallav L.
Title: Challenges of evaluating lung function as part of cancer care during the COVID-19 pandemic Cord-id: muefay2n Document date: 2020_7_2
ID: muefay2n
Snippet: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a newly identified agent foisted upon humanity and responsible for the contagious affliction, coronavirus disease 2019 (COVID-19) [1] that has rapidly evolved into a pandemic testing to their limits, and sometimes beyond, the capacity to respond of healthcare systems across the world [2]. Management is purely supportive and social isolation crucial to containment [3]. Enforced reallocation of hospital resources and personnel to cope
Document: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a newly identified agent foisted upon humanity and responsible for the contagious affliction, coronavirus disease 2019 (COVID-19) [1] that has rapidly evolved into a pandemic testing to their limits, and sometimes beyond, the capacity to respond of healthcare systems across the world [2]. Management is purely supportive and social isolation crucial to containment [3]. Enforced reallocation of hospital resources and personnel to cope with the increasing numbers requiring hospital admission and intensive care [4] in the most trying of conditions has been at the expense of many hospital departments, among them those offering diagnostic and support services for lung cancer [5–7].
Search related documents:
Co phrase search for related documents- accurate prediction and lung cancer: 1, 2
- accurate prediction and lung cancer patient: 1
- accurate prediction and lung function: 1, 2
- acute respiratory and low attenuation: 1, 2, 3
- acute respiratory and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- acute respiratory and lung cancer patient: 1, 2, 3, 4, 5, 6, 7, 8
- acute respiratory and lung capacity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48
- acute respiratory and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- acute respiratory and lung function evaluate: 1, 2, 3, 4
- acute respiratory and lung function test: 1, 2, 3, 4, 5
- acute respiratory and lung physiology: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- acute respiratory and lung physiology evaluation: 1
- low attenuation and lung cancer: 1
- low attenuation and lung capacity: 1, 2
- low attenuation and lung function: 1
Co phrase search for related documents, hyperlinks ordered by date